Cargando…
Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review
Patients with advanced duodenal carcinoma usually have a poor prognosis due to limited effective chemotherapy options. The study for genotype-directed therapy in patients with duodenal carcinoma is progressing. However, no clinical data assessing the efficacy of molecularly targeted therapy are pres...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878825/ https://www.ncbi.nlm.nih.gov/pubmed/36713517 http://dx.doi.org/10.3389/fonc.2022.1064944 |